2
Clinical Trials associated with FMP-010 vaccine(Walter Reed Army Institute of Research)Phase 1a Open-label Dose Escalation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Candidate Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered Intramuscularly With GSK Biologicals' Adjuvant AS01B in Healthy Malaria-Naïve Adults
The purpose of this study is to determine whether an investigational malaria vaccine is safe and induces an immune response against malaria when tested in adults living in the United States.
Phase 1b Controlled Double Blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Candidate Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered Intramuscularly With Glaxo Smith Kline (GSK) Biologicals' Adjuvant AS01B
The purpose of this study is to determine whether an investigational malaria vaccine is safe and induces an immune response against malaria when tested in adults living in the United States.
100 Clinical Results associated with FMP-010 vaccine(Walter Reed Army Institute of Research)
100 Translational Medicine associated with FMP-010 vaccine(Walter Reed Army Institute of Research)
100 Patents (Medical) associated with FMP-010 vaccine(Walter Reed Army Institute of Research)
100 Deals associated with FMP-010 vaccine(Walter Reed Army Institute of Research)